Testicular cancer stem cell hypothesis – diagnostic and therapeutic implications

Marija Daković Bjelaković; Slobodan Vlajković; Goran Bjelaković; Milorad Antić

doi:10.2298/VSP170821197D

Marija Daković Bjelaković Institute of Anatomy, Medical Faculty, University of Nis
Slobodan Vlajković Institute of Anatomy, Medical Faculty, University of Nis
Goran Bjelaković Department of Internal medicine, Medical Faculty, University of Nis
Milorad Antić Institute of Anatomy, Medical Faculty, University of Nis

DOI: https://doi.org/10.2298/VSP170821197D

Keywords: diagnosis;, carcinogenesis;, testicular neoplasms;, therapeutics

Author Biographies

Marija Daković Bjelaković, Institute of Anatomy, Medical Faculty, University of Nis

None known

Slobodan Vlajković, Institute of Anatomy, Medical Faculty, University of Nis

Professor

Goran Bjelaković, Department of Internal medicine, Medical Faculty, University of Nis

Professor

Milorad Antić, Institute of Anatomy, Medical Faculty, University of Nis

Assistant

References

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69‒90.

Rosen A, Jayram G, Drazer M, Eggener SE. Global trends in testicular cancer incidence and mortality. Eur Urol 2011; 60(2): 374‒9.

Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: an overview. Int J Cancer 2005; 116(3): 331‒9.

Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Møller H. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 2006; 118(12): 3099‒111.

Cheng L, Albers P, Berney DM, Feldman DR, Daugaard G, Gilli-gan T, et al. Testicular cancer. Nat Rev Dis Primers 2018; 4(1): 29.

Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019; 144(8): 1941‒53.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394‒424.

Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol 2016; 70(1): 93‒105.

ICD-O: International Classification of Diseases for Oncol-ogy. 3 ed. Geneva: World Health Organization; 2000.

Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. Guidelines on Testicular Cancer: 2015 Update. Eur Urol 2015;68(6):1054‒68.

Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997; 337(4): 242‒53.

Rajpert-De Meyts E. Developmental model for the pathogen-esis of testicular carcinoma in situ: genetic and environmen-tal aspects. Hum Reprod Update 2006; 12(3): 303‒23.

Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA. A systematic review and meta-analysis of peri-natal variables in relation to the risk of testicular cancer - experiences of the son. Int J Epidemiol 2010; 39(6): 1605‒18.

Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004; 44: 239‒67.

Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 2010; 38(1): 96‒109.

Celino FT, Yamaguchi S, Miura C, Ohta T, Tozawa Y, Iwai T, et al. Tolerance of Spermatogonia to Oxidative Stress Is Due to High Levels of Zn and Cu/Zn Superoxide Dismutase. PLoS One 2011; 6(2): e16938.

Cvetkovic T, Stankovic J, Najman S, Pavlovic D, Stokanovic D, Vlajkovic S, et al. Oxidant and antioxidant status in experi-mental rat testis after testicular torsion/detorsion. Int J Fert Steril 2015; 9(1): 121‒8.

Hoei-Hansen CE, Rajpert-De Meyts E, Daugaard G, Skakkebaek NE. Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review. Ann Oncol 2005; 16(6): 863‒8.

Skakkebaek NE. Possible carcinoma-in-situ of the testis. Lan-cet 1972; 2(7776): 516‒7.

Skakkebek NE, Berthelsen JG. Carcinoma-in-situ of testis and orchiectomy. Lancet 1978; 2(8082): 204‒5.

Almstrup K, Sonne SB, Hoei-Hansen CE, Ottesen AM, Nielsen JE, Skakkebaek NE, et al. From embryonic stem cells to testicu-lar germ cell cancer - should we be concerned? Int J Androl 2006; 29(1): 211‒8.

van de Geijn GJ, Hersmus R, Looijenga LH. Recent develop-ments in testicular germ cell tumor research. Birth Defects Res C Embryo Today 2009; 87(1): 96‒113.

Presnell SC, Petersen B, Heidaran M. Stem cells in adult tissues. Semin Cell Dev Biol 2002; 13(5): 369‒76.

Vlajkovic S, Cukuranovic R, Dakovic Bjelakovic M, Stefanovic V. Possible therapeutic use of spermatogonial stem cells in the treatment of male infertility: a brief overview. Sci World J 2012; 2012: 374151.

Sell S. Stem cell origin of cancer and differentiation thera-py. Crit Rev Oncol Hematol 2004; 51(1): 1‒28.

Crowe DL, Parsa B, Sinha UK. Relationships between stem cells and cancer stem cells. Histol Histopathol 2004; 19(2): 505‒9.

Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, can-cer and cancer stem cells. Nature 2001; 414(6859): 105‒11.

Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev 2004; 14(1): 43‒7.

Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res 2006; 66(4): 1883‒90.

Dick JE. Acute myeloid leukemia stem cells. Ann N Y Acad Sci 2005; 1044: 1‒5.

Sell S. On the stem cell origin of cancer. Am J Pathol 2010; 176(6): 2584‒94.

Costa FF, Le Blanc K, Brodin B. Concise review: cancer/testis antigens, stem cells, and cancer. Stem Cells 2007; 25(3): 707‒11.

Smith GH, Chepko G. Mammary epithelial stem cells. Mi-crosc Res Tech 2001; 52(2): 190‒203.

Giwercman A, Müller J, Skakkebaek NE. Prevalence of carci-noma in situ and other histopathological abnormalities in testes from 399 men who died suddenly and unexpectedly. J Urol 1991; 145(1): 77‒80.

Holstein AF, Laure H. Histologic diagnostics of early testicu-lar germ-cell tumor. Int J Urol 1996; 3(3): 165‒72.

Dieckmann KP, Skakkebaek NE. Carcinoma in situ of the tes-tis: review of biological and clinical features. Int J Cancer 1999; 83(6): 815‒22.

Jacobsen GK, Nørgaard-Pedersen B. Placental alkaline phospha-tase in testicular germ cell tumours and in carcinoma-in-situ of the testis. An immunohistochemical study. Acta Pathol Microbiol Immunol Scand A 1984; 92(5): 323‒9.

Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gil-lis AJ, van Roozendaal KE, et al. POU5F1 (OCT3/4) identi-fies cells with pluripotent potential in human germ cell tu-mors. Cancer Res 2003; 63(9): 2244‒50.

Giwercman A, Cantell L, Marks A. Placental-like alkaline phosphatase as a marker of carcinoma-in-situ of the testis. Comparison with monoclonal antibodies M2A and 43-9F. APMIS 1991; 99(7): 586‒94.

Giwercman A, Andrews PW, Jørgensen N, Müller J, Graem N, Skakkebaek NE. Immunohistochemical expression of em-bryonal marker TRA-1-60 in carcinoma in situ and germ cell tumors of the testis. Cancer 1993; 72(4): 1308‒14.

Kang JL, Rajpert-De Meyts E, Skakkebaek NE. Immunoreac-tive neuron-specific enolase (NSE) is expressed in testicular carcinoma-in-situ. J Pathol 1996; 178(2): 161‒5.

Rajpert-De Meyts E, Skakkebaek NE. Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours. Int J Androl 1994; 17(2): 85‒92.

Jørgensen N, Giwercman A, Müller J, Skakkebaek NE. Immuno-histochemical markers of carcinoma in situ of the testis also expressed in normal infantile germ cells. Histopathology 1993; 22(4): 373‒8.

Jørgensen N, Rajpert-De Meyts E, Graem N, Müller J, Giwercman A, Skakkebaek NE. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest 1995; 72(2): 223‒31.

Subramaniam D, Ramalingam S, Houchen CW, Anant S. Cancer stem cells: a novel paradigm for cancer prevention and treatment. Mini Rev Med Chem 2010; 10(5): 359‒71.

Pierpont TM, Lyndaker AM, Anderson CM, Jin Q, Moore ES, Ro-den JL, et al. Chemotherapy-Induced Depletion of OCT4-Positive Cancer Stem Cells in a Mouse Model of Malignant Testicular Cancer. Cell Rep 2017; 21(7): 1896‒909.

Rajpert-De Meyts E, McGlynn KA, Okamoto K, Jewett MA, Bokemeyer C. Testicular germ cell tumours. Lancet 2016; 387(10029): 1762‒74.

Shukla G, Khera HK, Srivastava AK, Khare P, Patidar R, Saxena R. Therapeutic potential, challenges and future perspective of cancer stem cells in translational oncology: a critical re-view. Curr Stem Cell Res Ther 2017; 12(3): 207‒24.

Zhao Y, Dong Q, Li J, Zhang K, Qin J, Zhao J, et al. Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies. Semin Cancer Biol 2018; 53: 139‒55.